CEBP 09 AM Call for Abstracts w/deadline 2008 Conference on Cancer Prevention - Washington, D.C.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Marshall, L. M.
Right arrow Articles by Colditz, G. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Marshall, L. M.
Right arrow Articles by Colditz, G. A.

Cancer Epidemiology Biomarkers & Prevention, Vol 6, Issue 5 297-301, Copyright © 1997 by American Association for Cancer Research


ARTICLES

Risk of breast cancer associated with atypical hyperplasia of lobular and ductal types

LM Marshall, DJ Hunter, JL Connolly, SJ Schnitt, C Byrne, SJ London and GA Colditz
Channing Laboratory, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA.

Epidemiological studies using the histological classification of Page for benign breast disease consistently demonstrate a positive association between atypical hyperplasia and the subsequent development of breast cancer. However, atypical hyperplasia is of either lobular or ductal types, and breast cancer risk in relation to type of atypical hyperplasia has not been studied extensively. Thus, we investigated prospectively the risk of breast cancer associated with histological subtypes of benign proliferative breast disease, including the types of atypical hyperplasia, among participants in the Nurses' Health Study who had biopsy-confirmed benign breast disease. Women who subsequently developed breast cancer were matched by year of birth and year of biopsy to participants who were free from breast cancer. Benign biopsy slides were classified according to the criteria of Page. Odds ratios (ORs) of breast cancer and 95% confidence intervals (CIs), adjusted for the matching variables and other breast cancer risk factors, were computed using unconditional logistic regression with benign nonproliferative breast disease as the referent group. Atypical ductal hyperplasia (OR = 2.4; 95% CI, 1.3-4.5) or atypical lobular hyperplasia (OR = 5.3; 95% CI, 2.7-10.4) in a prior biopsy were associated with increased breast cancer risk. Atypical lobular hyperplasia was more strongly associated with the risk of premenopausal breast cancer (OR = 9.6; 95% CI, 3.3-27.8) than with the risk of postmenopausal breast cancer (OR = 3.7; 95% CI, 1.3-10.2). The association of atypical ductal hyperplasia and breast cancer risk varied little by menopausal status. The magnitude of breast cancer risk seems to vary according to the type of atypical hyperplasia present at biopsy.


This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
M. J. Worsham, U. Raju, M. Lu, A. Kapke, J. Cheng, and S. R. Wolman
Multiplicity of Benign Breast Lesions Is a Risk Factor for Progression to Breast Cancer
Clin. Cancer Res., September 15, 2007; 13(18): 5474 - 5479.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
A. C. Degnim, D. W. Visscher, H. K. Berman, M. H. Frost, T. A. Sellers, R. A. Vierkant, S. D. Maloney, V. S. Pankratz, P. C. de Groen, W. L. Lingle, et al.
Stratification of Breast Cancer Risk in Women With Atypia: A Mayo Cohort Study
J. Clin. Oncol., July 1, 2007; 25(19): 2671 - 2677.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
E. L. Ashbeck, R. D. Rosenberg, P. M. Stauber, and C. R. Key
Benign Breast Biopsy Diagnosis and Subsequent Risk of Breast Cancer
Cancer Epidemiol. Biomarkers Prev., March 1, 2007; 16(3): 467 - 472.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
M. C. Mahoney, T. M. Robinson-Smith, and E. A. Shaughnessy
Lobular Neoplasia at 11-Gauge Vacuum-Assisted Stereotactic Biopsy: Correlation with Surgical Excisional Biopsy and Mammographic Follow-Up
Am. J. Roentgenol., October 1, 2006; 187(4): 949 - 954.
[Abstract] [Full Text] [PDF]


Home page
The OncologistHome page
M. Guray and A. A. Sahin
Benign breast diseases: classification, diagnosis, and management.
Oncologist, May 1, 2006; 11(5): 435 - 449.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
J. A. Baker, G. P. Beehler, A. C. Sawant, V. Jayaprakash, S. E. McCann, and K. B. Moysich
Consumption of Coffee, but Not Black Tea, Is Associated with Decreased Risk of Premenopausal Breast Cancer
J. Nutr., January 1, 2006; 136(1): 166 - 171.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
D. L. Page and J. F. Simpson
What Is Atypical Lobular Hyperplasia and What Does It Mean for the Patient?
J. Clin. Oncol., August 20, 2005; 23(24): 5432 - 5433.
[Full Text] [PDF]


Home page
JCOHome page
P. J. Chuba, M. R. Hamre, J. Yap, R. K. Severson, D. Lucas, F. Shamsa, and A. Aref
Bilateral Risk for Subsequent Breast Cancer After Lobular Carcinoma-In-Situ: Analysis of Surveillance, Epidemiology, and End Results Data
J. Clin. Oncol., August 20, 2005; 23(24): 5534 - 5541.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
L. C. Hartmann, T. A. Sellers, M. H. Frost, W. L. Lingle, A. C. Degnim, K. Ghosh, R. A. Vierkant, S. D. Maloney, V. S. Pankratz, D. W. Hillman, et al.
Benign Breast Disease and the Risk of Breast Cancer
N. Engl. J. Med., July 21, 2005; 353(3): 229 - 237.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
E. Tan-Chiu, J. Wang, J. P. Costantino, S. Paik, C. Butch, D. L. Wickerham, B. Fisher, and N. Wolmark
Effects of Tamoxifen on Benign Breast Disease in Women at High Risk for Breast Cancer
J Natl Cancer Inst, February 19, 2003; 95(4): 302 - 307.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
C. Byrne, P. M. Webb, T. W. Jacobs, G. Peiro, S. J. Schnitt, J. L. Connolly, W. C. Willett, and G. A. Colditz
Alcohol Consumption and Incidence of Benign Breast Disease
Cancer Epidemiol. Biomarkers Prev., November 1, 2002; 11(11): 1369 - 1374.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
D. B. Thomas, R. A. Carter, W. H. Bush Jr., R. M. Ray, J. L. Stanford, C. D. Lehman, J. R. Daling, K. Malone, and S. Davis
Risk of Subsequent Breast Cancer in Relation to Characteristics of Screening Mammograms from Women Less Than 50 Years of Age
Cancer Epidemiol. Biomarkers Prev., June 1, 2002; 11(6): 565 - 571.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
A. M. Shaaban, J. P. Sloane, C. R. West, and C. S. Foster
Breast Cancer Risk in Usual Ductal Hyperplasia Is Defined by Estrogen Receptor-{alpha} and Ki-67 Expression
Am. J. Pathol., February 1, 2002; 160(2): 597 - 604.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
M. B. Daly and E. A. Ross
Predicting Breast Cancer: the Search for a Model
J Natl Cancer Inst, August 2, 2000; 92(15): 1196 - 1197.
[Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
C. J. Fabian, B. F. Kimler, C. M. Zalles, J. R. Klemp, S. Kamel, S. Zeiger, and M. S. Mayo
Short-Term Breast Cancer Prediction by Random Periareolar Fine-Needle Aspiration Cytology and the Gail Risk Model
J Natl Cancer Inst, August 2, 2000; 92(15): 1217 - 1227.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
H. Gobbi, W. D. Dupont, J. F. Simpson, W.D. Plummer Jr., P. A. Schuyler, S. J. Olson, C. L. Arteaga, and D. L. Page
Transforming Growth Factor-{beta} and Breast Cancer Risk in Women With Mammary Epithelial Hyperplasia
J Natl Cancer Inst, December 15, 1999; 91(24): 2096 - 2101.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
D. M. Gertig, I. E. Stillman, C. Byrne, D. Spiegelman, S. J. Schnitt, J. L. Connolly, G. A. Colditz, and D. J. Hunter
Association of Age and Reproductive Factors with Benign Breast Tissue Composition
Cancer Epidemiol. Biomarkers Prev., October 1, 1999; 8(10): 873 - 879.
[Abstract] [Full Text]


Home page
NEJMHome page
T. W. Jacobs, C. Byrne, G. Colditz, J. L. Connolly, and S. J. Schnitt
Radial Scars in Benign Breast-Biopsy Specimens and the Risk of Breast Cancer
N. Engl. J. Med., February 11, 1999; 340(6): 430 - 436.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1997 by the American Association for Cancer Research.